Ownership and insider activity for Dr. Reddy's Laboratories Limited (RDY): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products.
Price
| Price | $12.32 |
| Market Cap | $10.3B |
| Exchange | NYSE |
| Country | IN |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-04-01 | MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN | |||
| 2025-12-18 | AGHANIAN PATRICK RUDOLF | |||
| 2025-12-18 | KALAWADIA MILAN KANTILAL | |||
| 2025-12-18 | MOTUPALLI VENKATA RAMANA | |||
| 2025-12-18 | Israeli Erez | |||
| 2025-12-18 | VENKATESH KRISHNA | |||
| 2025-12-18 | KULKARNI SUSHRUT | |||
| 2025-12-18 | BHETHANABOTTLA SRINIVASA PHANIMITRA | |||
| 2025-12-18 | MANNAM VENKATA NARASIMHAM | |||
| 2025-12-18 | SAPRA DEEPAK |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 18.14B INR | 2.64B INR | 2.23B INR | 27.1M INR | 202.8M INR | 14.85B INR | 5.78B INR | 7.11B INR | 14.65B INR | 15.06B INR |
| Short-term Investments | 0 | 18.33B INR | 22.53B INR | 313.1M INR | 270.0M INR | 29.51B INR | 56.02B INR | 74.36B INR | 43.25B INR | 71.01B INR |
| Receivables | 45.74B INR | 50.20B INR | 46.63B INR | 816.3M INR | 843.7M INR | 80.27B INR | 83.20B INR | 95.34B INR | 109.79B INR | 99.22B INR |
| Inventory | 28.53B INR | 29.09B INR | 33.58B INR | 463.5M INR | 621.1M INR | 50.88B INR | 48.67B INR | 63.55B INR | 71.08B INR | 75.02B INR |
| Total Current Assets | 100.38B INR | 109.64B INR | 114.50B INR | 1.72B INR | 2.03B INR | 181.86B INR | 204.25B INR | 248.05B INR | 250.11B INR | 296.00B INR |
| Property, Plant & Equipment | 57.16B INR | 57.87B INR | 54.09B INR | 691.8M INR | 781.1M INR | 62.17B INR | 66.46B INR | 76.89B INR | 97.76B INR | 113.63B INR |
| Goodwill | 3.75B INR | 3.94B INR | 3.90B INR | 52.8M INR | 62.5M INR | 4.42B INR | 4.25B INR | 4.25B INR | 11.81B INR | 12.64B INR |
| Intangible Assets | 44.92B INR | 44.66B INR | 44.37B INR | 365.6M INR | 487.6M INR | 27.25B INR | 30.85B INR | 36.95B INR | 96.80B INR | 102.98B INR |
| Total Assets | 219.82B INR | 225.60B INR | 225.43B INR | 3.07B INR | 3.63B INR | 292.83B INR | 321.85B INR | 387.52B INR | 492.99B INR | 567.88B INR |
| Accounts Payable | 0 | 9.21B INR | 10.30B INR | 142.0M INR | 173.6M INR | 15.97B INR | 17.86B INR | 21.55B INR | 20.05B INR | 32.75B INR |
| Short-term Debt | 43.74B INR | 25.56B INR | 16.32B INR | 274.9M INR | 328.4M INR | 27.08B INR | 11.19B INR | 12.72B INR | 38.05B INR | 63.85B INR |
| Total Current Liabilities | 85.00B INR | 69.69B INR | 59.70B INR | 962.5M INR | 1.14B INR | 94.02B INR | 85.84B INR | 96.04B INR | 130.39B INR | 164.25B INR |
| Long-term Debt | 4.85B INR | 24.46B INR | 21.45B INR | 0 | 52.0M INR | 3.80B INR | 0 | 3.80B INR | 3.80B INR | 11.96B INR |
| Total Liabilities | 95.78B INR | 99.14B INR | 85.23B INR | 1.02B INR | 1.26B INR | 102.30B INR | 90.86B INR | 106.97B INR | 155.82B INR | 194.95B INR |
| Retained Earnings | 108.22B INR | 113.86B INR | 128.65B INR | 1.91B INR | 2.13B INR | 175.71B INR | 215.59B INR | 265.26B INR | 315.79B INR | 345.02B INR |
| Total Equity | 124.04B INR | 126.46B INR | 140.20B INR | 2.05B INR | 2.37B INR | 190.53B INR | 230.99B INR | 280.55B INR | 333.39B INR | 369.60B INR |
| Total Debt | 49.19B INR | 50.71B INR | 38.38B INR | 292.2M INR | 414.5M INR | 33.84B INR | 13.47B INR | 20.02B INR | 46.77B INR | 75.81B INR |
| Net Debt | 31.05B INR | 29.75B INR | 13.62B INR | -48.1M INR | -58.3M INR | -10.52B INR | -48.33B INR | -61.45B INR | -11.14B INR | -10.27B INR |
| Working Capital | 15.38B INR | 39.95B INR | 54.80B INR | 760.8M INR | 887.1M INR | 87.84B INR | 118.41B INR | 152.01B INR | 119.72B INR | 131.75B INR |
Financial Health
| Debt / Equity | 0.19 |
| Current Ratio | 1.90 |
Profitability
| Return on Equity | 12.20% |
| Return on Invested Capital | 8.10% |
| Return on Assets | 7.94% |
| Gross Margin | 50.18% |
| Operating Margin | 10.64% |
| Net Margin | 10.00% |
Related companies: BMRN · EHC · ELAN · ENSG · EXEL · NBIX · RVMD
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of RDY: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks